Cargando…
Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis
Cystic fibrosis (CF) is an autosomal recessive genetic condition that is caused by variants in the cystic fibrosis transmembrane conductance regulator gene. This causes multisystem disease due to dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) ion channel at the apical...
Autores principales: | Haq, Iram, Almulhem, Maryam, Soars, Simone, Poulton, David, Brodlie, Malcolm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828078/ https://www.ncbi.nlm.nih.gov/pubmed/35153502 http://dx.doi.org/10.2147/PGPM.S245603 |
Ejemplares similares
-
Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015) -
Exploring the impact of elexacaftor-tezacaftor-ivacaftor treatment on opinions regarding airway clearance techniques and nebulisers: TEMPO a qualitative study in children with cystic fibrosis, their families and healthcare professionals
por: Almulhem, Maryam, et al.
Publicado: (2022) -
Trends in nontuberculous mycobacteria infection in children and young people with cystic fibrosis
por: Abidin, Noreen Zainal, et al.
Publicado: (2021) -
CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias
Publicado: (2016) -
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
por: Lopes-Pacheco, Miquéias
Publicado: (2020)